By DAVID GELLES
In the last week, a joint bid for Allergan, the maker of Botox, has evolved from an already unusual deal into one of the most confounding takeover attempts in recent memory.
Published: June 2, 2014 at 4:00AM
from NYT Business Day http://ift.tt/1hRU6rp
via IFTTT
from WordPress http://ift.tt/1ooOetu
No comments:
Post a Comment